BioCentury
ARTICLE | Financial News

Radius postpones IPO

May 10, 2014 1:54 AM UTC

Two Wall Street sources told BioCentury that Radius Health Inc. (Cambridge, Mass.) postponed its IPO on NASDAQ for the second time, citing market conditions. The company declined to comment, saying it is in a quiet period. Last month, the company amended its IPO to sell 5 million shares at $14-$16. At the $15 midpoint, the company would have raised $75 million and been valued at $389.3 million. The company filed to raise up to $86.3 million in the IPO in February. Jefferies; Cowen; Canaccord; and Cantor Fitzgerald were underwriters. Radius first postponed an IPO in 2012, also citing market conditions. ...